Treating advanced cancer in an era of increasing cost consciousness

Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

International journal of clinical oncology·2013

Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin's lymphoma.

Rheumatology (Oxford, England)·2005

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

Cancer·2001

Confounding by indication in the evaluation of neoadjuvant chemotherapy: a sequential Cox analysis of an eight-year single-centre breast cancer cohort.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

OncoTargets and therapy·2026

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Case reports in oncology·2026

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Mediastinum (Hong Kong, China)·2026

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Mediastinum (Hong Kong, China)·2026

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Mediastinum (Hong Kong, China)·2026

Related Experiment Videos

Treating advanced cancer in an era of increasing cost consciousness

Related Concept Videos

Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.

Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT.

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin's lymphoma.

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

Confounding by indication in the evaluation of neoadjuvant chemotherapy: a sequential Cox analysis of an eight-year single-centre breast cancer cohort.

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Related Experiment Videos

Treating advanced cancer in an era of increasing cost consciousness

Related Concept Videos

Related Articles